ATTILI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 943
EU - Europa 100
AS - Asia 91
OC - Oceania 1
Totale 1.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 942
IT - Italia 47
SG - Singapore 47
CN - Cina 34
SE - Svezia 22
FR - Francia 10
IN - India 10
DE - Germania 7
FI - Finlandia 7
GB - Regno Unito 3
NL - Olanda 2
AU - Australia 1
CA - Canada 1
ES - Italia 1
UA - Ucraina 1
Totale 1.135
Salva come PNG Salva come JPEG
Città #
Fairfield 200
Chandler 97
Woodbridge 96
Ashburn 84
Seattle 71
Houston 70
Cambridge 68
Wilmington 61
Ann Arbor 40
Singapore 36
San Diego 14
Medford 13
Princeton 13
Roxbury 12
Padova 11
Beijing 9
Santa Clara 9
Des Moines 7
Helsinki 7
Pune 7
Boardman 6
New York 6
Pignone 4
Nanchang 3
Cerro al Lambro 2
Grisignano di Zocco 2
Guangzhou 2
Los Angeles 2
Milan 2
Milazzo 2
Rome 2
Southwark 2
Avezzano 1
Bellaterra 1
Castelfranco Veneto 1
Frankfurt am Main 1
Gunzenhausen 1
Hangzhou 1
Hebei 1
Hefei 1
Jinan 1
Jolanda di Savoia 1
Kharkiv 1
Kunming 1
Lanzhou 1
London 1
Montreal 1
Norwalk 1
Ogden 1
Paris 1
Redwood City 1
San Floriano del Collio 1
San Francisco 1
Shenyang 1
Sydney 1
Tappahannock 1
Torino 1
Venice 1
Totale 986
Salva come PNG Salva come JPEG
Nome #
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 145
Immunotherapy in small-cell lung cancer: From molecular promises to clinical challenges 119
LKB1 and tumor metabolism: The interplay of immune and angiogenic microenvironment in lung cancer 114
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors 113
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy 92
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 92
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 91
Therapeutic approaches for T790M mutation positive non-small-cell lung cancer 86
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 70
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? 70
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer 66
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 53
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer 50
Totale 1.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.350
article - articoli 4.350
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 93 21 12 20 22 28 14 14 10
2020/2021290 12 12 11 7 10 38 57 18 29 45 17 34
2021/2022230 20 18 14 10 30 21 24 12 27 4 13 37
2022/2023144 23 20 8 24 25 15 0 10 12 3 3 1
2023/202495 5 15 7 14 3 22 0 10 5 2 5 7
2024/202584 2 51 13 18 0 0 0 0 0 0 0 0
Totale 1.161